期刊文献+

HPLC法测定多索茶碱注射液中的工艺杂质及降解产物 被引量:3

Determination of process impurities and degradation products in Doxofylline Injection by HPLC
下载PDF
导出
摘要 目的 建立多索茶碱注射液有关物质的测定方法。方法采用Agilent TC-C18(4.6 mmx250 mm,5μm)色谱柱;流动相:乙腈一磷酸盐缓冲液(pH 5.0)(20:80);柱温30℃;流速1.0 mL·min-1;检测波长274 nm。结果茶碱、杂质B、杂质D在0.031~9.62、0.043—9.080、0.126—10.561μg·mL-1浓度范围内,线性关系良好,相关系数r的数值不小于0.999;平均回收率分别为101.4%、99.3%、96.6%,RSD分别为0.3%、0.9%、1.4%(n=9)。结论 建立的方法灵敏度高,测定结果准确,可用于多索茶碱注射液中工艺杂质和降解产物的测定。 Objective To establish an HPLC method for the determination of process impurities and degradation prod-ucts in Doxofylline Injection.Methods The assay was performed on an Agilent TC-C1s column (4.6 mmx250 mm,5 μ)with acetonitrile-phosphate buffer(pH 5.0) (20:80) as mobile phase, the flow rate was 1.0 mL ·min-1, the column tem-perature was 30 ℃ and the detection wavelength was 274 nm.Results Good linearity was obtained in 0.031 -9.62,0.0439.080 and 0.126-10.561 μg · mL-1 for theophylline, impurity B and inmpurity D,respectively.The correlation coefficientwas at least 0.999.The average recovery rates of theophylline, impurity B and impurity D were 101.4% (RSD= 0.3%),99.3% ( RSD = 0.9% ), 96.6% ( RSD = 1.4%) , n = 9. Conclusion The method can be used for the determination of processimpurities and degradation products in Doxofylline Injection with high sensitivity, accurate and reliable results.
出处 《药学研究》 CAS 2016年第11期646-649,共4页 Journal of Pharmaceutical Research
关键词 多索茶碱 茶碱 高效液相色谱 杂质 Doxofylline Theophylline HPLC Impurity
  • 相关文献

参考文献8

二级参考文献18

  • 1郭辉,徐小莹,何丽一,黄俊华.多索茶碱在大鼠体内的药代动力学[J].药学学报,1997,32(2):81-84. 被引量:7
  • 2原正平,王汝龙.化学产品手册(药物).北京:化学工业出版社,1987
  • 3Barnes PJ. Theophylline : new perspectives for an old drug. Am J Respir Crit Care Med, 2003,167(6) : 813 -818.
  • 4Rabe KF, Magnussen H, Dent G. Theophylline and selective PDE inhibitors as bronchodilators and smooth muscle relaxants. Eur Respir J, 1995,8:637 - 642.
  • 5Teantes AE, Tassiopoulos ST, Papadhimitriou SI, et al. Theophylline treatment may adversely affect the anoxia - induced erythropoietic response without suppressing erythropoietin production. Eur J Clin Pharmacol,2003,59 (5 - 6) :379 - 383.
  • 6Culpitt SV, de Matos C, Russell RE, et al. Effect of theophylline on induced sputum inflammatory indices neutrophil chemotaxis in COPD. Am J Respir Crit Care Med,2002 ; 165 : 1371 - 1376.
  • 7Kobayashi M, Nasuhara Y, Betsuyakv T, et al. Effect of low-dose theophylline on airway inflammation in COPD. Reopirology, 2004,9:249 -254.
  • 8Ichiyama T, Hasegawa S, Matsubara T, et al . Theophylline inhibits NF-κB activation and I-κB degradation in human pulmonary epithelial cells. Naunyn Schmiedebergs Arch Pharmacol,2001,364 :558 -561.
  • 9Ito K, Hanazawa T, Tomita K, et al. Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression : role of tyrosine nitration. Biochem Biophys Res Commun, 2004,315:240-245.
  • 10Tsukagoshi H, Shinizu Y, Iwamae S, et al. Evidence of oxidative stress in asthma and COPD : Potential inhibitory effect of theophylline. Respir Med, 2002,94(6) :584 -588.

共引文献73

同被引文献15

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部